Intralipid Emulsion
Product Images NDC 0338-0519

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 0338-0519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 Pbp (Bag 20pbp)

This is a description of a pharmaceutical product called Intralipid® 20%, which is an I.V. Fat Emulsion contained in a 1000 mL Pharmacy Bulk Package. It should not be directly infused into the patient's body but is suitable for intravenous use. The NDC (National Drug Code) for this product is 0338-0519-14.*

FDA Label Image

Image 2 (Inforuse20p Image2)

This text provides instructions on how to open a package containing an item. The text suggests removing the overwrap by tearing at the notch and discarding the Oalert sachet and oxygen absorber. It then provides instructions on placing the bag on a clean, flat surface or hanging it on a support hook.*

FDA Label Image

Image 3 (Inforuse20p Image3)

This text provides instructions for breaking off a tamper-evident arrow flag from a blue infusion port and specifies the required diameter for using a compounding set.*

FDA Label Image

Image 4 (Inforuse20p Image4)

This text provides instructions on how to insert a spike through the center of an infusion port. It also advises the user to inspect the bag and its contents for any particulate matter before use and to discard the bag if there are any signs of discoloration or particulates.*

FDA Label Image

Image 5 (Inforuse20p Image5)

This text is a set of instructions on how to transfer contents from one bag to another. It suggests hanging the first bag on a hanger, and then simply cutting the bottom of the bag and allowing its contents to flow into the second bag, which is likely a compounding bag.*

FDA Label Image

Figure 1 (Instruct Fig1)

The Integrity indicator (Oxalert) should be inspected before removing the overwrap. If the indicator is black, the overwrap is damaged and the product should be discarded.*

FDA Label Image

Fatad (Intralipid 20 Pbp Excel Container Figure 1 Fatacid Intralp)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 10 Intra Figure8)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 11 Intra Figure9)

FDA Label Image

Figure (Intralipid 20 Pbp Excel Container Figure 12 Intra Figure)

FDA Label Image

Stuct (Intralipid 20 Pbp Excel Container Figure 13 Intra Figure12)

FDA Label Image

R1 (Intralipid 20 Pbp Excel Container Figure 2 R1c Intralip)

FDA Label Image

R2 (Intralipid 20 Pbp Excel Container Figure 3 R2c Intralip)

FDA Label Image

R3 (Intralipid 20 Pbp Excel Container Figure 4 R3c Intralp)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 5 Intra Figure3)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 6 Intra Figure4)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 7 Intra Figure5)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 8 Intra Figure6)

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 9 Intra Figure7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.